KILT

Boss Radio 66’s Tom Hanks and Debbie Daughtry Reveal Their Favorite 60s Tracks to Celebrate the Station’s One-Year Anniversary on TuneIn

Retrieved on: 
Tuesday, March 26, 2024
Classic Vinyl, KCOH, WABC, Boss, Algorithm, KYA, Country, The Mighty Hannibal, The Shirelles, SAN, Daughters of Eve (band), KILT, Female, Radio, KDAY, TuneIn, KHJ, Music, Night Tracks, History, Boss Radio

To celebrate, the team behind the eclectic 60s music station, Tom Hanks and Producer Debbie Daughtry, revealed their favorite songs from thousands of music tracks in the station library.

Key Points: 
  • To celebrate, the team behind the eclectic 60s music station, Tom Hanks and Producer Debbie Daughtry, revealed their favorite songs from thousands of music tracks in the station library.
  • Launched on TuneIn in March 2023, Boss Radio 66 was founded by Brooklyn Radio Producer Debbie Daughtry as an homage to the 1960s ‘Boss Radio’ format.
  • Huge congratulations to Debbie and Tom on the first anniversary of Boss Radio 66 on TuneIn.
  • To hear more from Daughtry and Hanks, listeners should also check out ‘ Country A-Go-Go ’ on TuneIn.

Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma

Retrieved on: 
Monday, June 12, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Hematopoietic stem cell transplantation, Classification, Lymphoma, KILT, Bone marrow, Euronext Paris, International Conference on Nuclear Disarmament, Oslo, 2008, IPH, Division, IPHA, Fungal infection, Conference, Pharmaceutical industry

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that interim efficacy results from the TELLOMAK Phase 2 study of lacutamab in advanced Mycosis Fungoides will be presented at the 17th International Conference on Malignant Lymphoma, being held in Lugano, June 13 – 17, 2023.

Key Points: 
  • Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that interim efficacy results from the TELLOMAK Phase 2 study of lacutamab in advanced Mycosis Fungoides will be presented at the 17th International Conference on Malignant Lymphoma, being held in Lugano, June 13 – 17, 2023.
  • Efficacy results will be presented according to updated lymph node classification.
  • Speaker: Dr. Pierluigi Porcu, Director, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Sidney Kimmel Cancer Center, Jefferson Health Philadelphia, US
    In addition, a Trial in Progress abstract of KILT, the Phase 2 study of lacutamab in peripheral T‑cell lymphoma led by The Lymphoma Study Association (LYSA) has been published in the 17‑ICML abstract book available online .

Cypher Capital Announces Gold Sponsorship of The Future Blockchain Summit

Retrieved on: 
Tuesday, October 4, 2022
Dubai World Trade Centre, Innovation, Solution, Mining, Entrepreneurship, Ecosystem, KILT, Industry, Security, Engineering, Semantic Web, Enterprise, Adoption, Into, Decentralized finance, Exhibition, MENA, Alpha, Investment, Partner, MICE, Metaon, NFT, Web 2.0, Shisha, Cryptocurrency, Renewable energy, Blockchain, Metaverse

DUBAI, UAE, Oct. 4, 2022 /PRNewswire/ -- Cypher Capital , a leading multi-strategy crypto investment firm based in the UAE, covering venture capital, public markets, nodes, mining and more, today announced that it will be supporting the 5th Future Blockchain Summit as a Gold Sponsor.

Key Points: 
  • DUBAI, UAE, Oct. 4, 2022 /PRNewswire/ -- Cypher Capital , a leading multi-strategy crypto investment firm based in the UAE, covering venture capital, public markets, nodes, mining and more, today announced that it will be supporting the 5th Future Blockchain Summit as a Gold Sponsor.
  • "Cypher Capital is pleased to be a Gold Sponsor of the 5th Future Blockchain Summit, an event that has contributed to the strategic growth of the blockchain and crypto space over the years," said Bijan Alizadeh, Co-Founder and Partner of Cypher Capital.
  • During the event, visitors and investors will have the chance to witness ten promising projects that Cypher Capital is backing.
  • Cypher Capital is a leading multi-strategy crypto investment firm based in the UAE, covering venture capital, public markets, nodes, mining, etc.

Cypher Capital Announces Gold Sponsorship of The Future Blockchain Summit

Retrieved on: 
Tuesday, October 4, 2022
Dubai World Trade Centre, Innovation, Solution, Mining, Entrepreneurship, Ecosystem, KILT, Industry, Security, Engineering, Semantic Web, Enterprise, Adoption, Into, Decentralized finance, Exhibition, MENA, Alpha, Investment, Partner, MICE, Metaon, NFT, Web 2.0, Shisha, Cryptocurrency, Renewable energy, Blockchain, Metaverse

DUBAI, UAE, Oct. 4, 2022 /PRNewswire/ -- Cypher Capital , a leading multi-strategy crypto investment firm based in the UAE, covering venture capital, public markets, nodes, mining and more, today announced that it will be supporting the 5th Future Blockchain Summit as a Gold Sponsor.

Key Points: 
  • DUBAI, UAE, Oct. 4, 2022 /PRNewswire/ -- Cypher Capital , a leading multi-strategy crypto investment firm based in the UAE, covering venture capital, public markets, nodes, mining and more, today announced that it will be supporting the 5th Future Blockchain Summit as a Gold Sponsor.
  • "Cypher Capital is pleased to be a Gold Sponsor of the 5th Future Blockchain Summit, an event that has contributed to the strategic growth of the blockchain and crypto space over the years," said Bijan Alizadeh, Co-Founder and Partner of Cypher Capital.
  • During the event, visitors and investors will have the chance to witness ten promising projects that Cypher Capital is backing.
  • Cypher Capital is a leading multi-strategy crypto investment firm based in the UAE, covering venture capital, public markets, nodes, mining, etc.